Medically assisted procreation (PMA) and surrogacy (GPA) spark intense ethical debates around procreation, bodily autonomy, filiation, and children's rights to origins. These techniques enable infertile individuals or couples—including those in same-sex relationships—to build families. Yet, public understanding remains limited, often leading to polarized views. As experts in reproductive medicine and bioethics, we'll clarify the key differences between PMA and GPA, and outline France's strict regulations, among Europe's most conservative.
A quick biology refresher: Sperm (male gametes) fertilize oocytes (female gametes, which become eggs post-fertilization) to create embryos. Fertility issues can disrupt this, which is where PMA—medically assisted procreation (also known as ART or assisted reproductive technology)—steps in. It encompasses techniques to handle sperm and/or eggs for pregnancy, including preventing severe genetic diseases. In France, about 1 in 30 children is born via PMA since the first 'test-tube baby' in 1982. Primary methods: artificial insemination and in vitro fertilization (IVF).
Artificial Insemination involves placing partner or donor sperm into the uterus during ovulation, allowing natural fertilization. Donor anonymity poses key challenges.
In Vitro Fertilization (IVF) fertilizes gametes (from parents and/or donors) in a lab, then transfers the embryo to the uterus.
GPA is an IVF variant where a third party—the surrogate mother—carries the pregnancy for intended parents. Essential for women unable to gestate (e.g., due to uterine issues) or male same-sex couples. The surrogate has no intent to parent; if she donates her oocyte too, it's 'procreation for others.'
France bans GPA under the principle of bodily unavailability, prohibiting contractual use of the body. This aligns more with non-commercialization (seen globally), though exceptions exist. Where legal, GPA can be compensated (e.g., Romania, the only EU country) or altruistic (e.g., UK).
The 2021 bioethics law (effective June 29) expanded access while maintaining limits. Previously for infertile heterosexual couples under 43 (after 1-year attempts), PMA now includes single women and female couples, plus double gamete donation without requiring a biological link.
Transgender individuals are excluded, as access hinges on civil status—not biology. A trans man with a uterus can't access PMA post-status change.
Children conceived via PMA can now request donor identities at majority via the origins commission; donors must consent (pre-law donors may opt out). Anonymity persists: doctors select donors based on resemblance criteria—no parental choice.
'Home' or artisanal donations (e.g., from relatives) are illegal, violating anonymity, gratuity, and health standards. Posthumous use of frozen sperm requires the donor to be alive.
GPA remains strictly prohibited since 1994 to prevent commodification of bodies and children, disadvantaging male couples (limited to adoption). A black/gray market persists via international options. Since 2017, France recognizes foreign-born GPA children, allowing the non-biological parent's adoption.
